Tag archive for ‘Opko Health Inc.’

OPKO buying Bio-Reference Laboratories for $1.5 billion

Opko Health Inc. (NYSE: OPK; TASE: OPK), has agreed to buy Bio-Reference Laboratories Inc.(Nasdaq: BRLI) in a deal valued at about $1.5 billion. Opko said it will pay 2.75 shares for each Bio-Reference Labs More...

Ilan Shavit On Wednesday, May 6th, 2015

Phillip Frost’s OPKO Health Acquires EirGen Pharma for $135 million in cash and shares

  Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost,  has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland,  focused on the development and More...

Globes On Wednesday, August 21st, 2013

Phillip Frost’s Opko rises strongly on TASE debut

– Phillip Frost: What Israel needs today is 10 companies like Teva; one is not enough. – Phillip Frost / Getty – / By Gali Weinreb / Dr. Phillip Frost, chairman and CEO of biomed company More...

Wordpress site Developed by Fixing WordPress Problems